Optimizing diagnostic strategies for central adrenal insufficiency in pituitary disease
Authors' conclusion
This study reaffirms the value of 11-DOF in the OMT as a reliable diagnostic tool for CAI, while confirming the limitations of the SST. These data indicate to consider SST as a single test procedure for low-risk patients.
Study context
- Population
- Patients with pituitary disease or after pituitary surgery and suspected central adrenal insufficiency (CAI)
- Participants
- 134 vs 156
- Comparison
- Overnight metyrapone test (OMT) vs short synacthen test (SST) for central adrenal insufficiency
- OMTn = 134
- SSTn = 156
- Outcome
- Diagnostic accuracy for CAI vs clinical outcome evaluation
- Follow-up
- Mean of 2.7 years
Methodological detailsretrospective, single-centre
- Retrospective
- Single-centre
Performance
As reported in the abstract
| Strategy | Sensitivity | Specificity |
|---|---|---|
| OMT | 100% | 94% |
| SST | 75.0% | 80.2% |
Sensitivity
OMT100%
SST75.0%
Specificity
OMT94%
SST80.2%
Further findings
- NPV of SST in low-risk group (CAI-Score = 0)
- 0.99
- SST showed no clear benefit in the other risk groups
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Optimizing diagnostic strategies for central adrenal insufficiency in pituitary disease. Eur J Endocrinol. Published 13 February 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →